The effect of cold ischemic time on the immunohistochemical evaluation of estrogen receptor, progesterone receptor, and HER2 expression in invasive breast carcinoma

The American Society of Clinical Oncology/College of American Pathologist (ASCO/CAP) guidelines on breast cancer currently recommend a cold ischemic time of

Saved in:
Bibliographic Details
Published in:Modern pathology 2012-08, Vol.25 (8), p.1098-1105
Main Authors: Yildiz-Aktas, Isil Z, Dabbs, David J, Bhargava, Rohit
Format: Article
Language:English
Subjects:
692/699/67/1347
692/700/139/422
692/700/1538
Antibodies
Biomarkers
Biomarkers, Tumor - analysis
Biopsy
Biopsy, Large-Core Needle
Breast cancer
breast carcinoma
Breast Neoplasms - chemistry
Breast Neoplasms - pathology
Breast Neoplasms - surgery
Cancer therapies
Carcinoma, Ductal, Breast - chemistry
Carcinoma, Ductal, Breast - pathology
Carcinoma, Ductal, Breast - surgery
Cloning
Cold Ischemia
cold ischemic time
Cryopreservation - methods
Epidermal growth factor
ER/PR/HER2
Estrogens
Female
Fixatives
Humans
Immunohistochemistry - methods
Ischemia
Laboratory Medicine
Medicine
Medicine & Public Health
Mortality
Oncology
original-article
Pathology
Prospective Studies
Receptor, ErbB-2 - analysis
Receptors, Estrogen - analysis
Receptors, Progesterone - analysis
Staining and Labeling
Time Factors
Tissue Fixation - methods
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The American Society of Clinical Oncology/College of American Pathologist (ASCO/CAP) guidelines on breast cancer currently recommend a cold ischemic time of
ISSN:0893-3952
1530-0285
DOI:10.1038/modpathol.2012.59